| year | Average | Low | High | Change from close on 2022-04-14 |
| 2022 | $1.81 | $1.52 | $1.99 | 5.52 % |
| 2023 | $1.25 | $1.15 | $1.39 | -27.25 % |
| 2024 | $1.33 | $1.31 | $1.34 | -22.67 % |
| 2025 | $1.31 | $1.27 | $1.37 | -23.85 % |
How high will Sens stock go by 2022?
But by 2022 revenue is forecast to go up by over 6 times to $32.90 million. At a market cap of $974 million SENS stock trades for 30 times forward revenue multiple.
Will Sens stock move up soon?
As such, SENS stock is likely to move up quite a bit soon. DexCom is a much larger company whose stock has risen over 21 times in the past 10 years. It brought to market its CGM products over successive iterations during that period.
Should you hold senseonics (Sens) stock?
The consensus among Wall Street equities research analysts is that investors should "hold" Senseonics stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SENS, but not buy additional shares or sell existing shares. View analyst ratings for Senseonics or view top-rated stocks.
Is Sens stock headed for a short squeeze?
SENS stock’s high short interest could lead to a squeeze. According to the most recent filing, SENS stock has a short interest ratio of almost 18 percent. The short interest looks high enough to trigger a short squeeze.
Where will SENS stock be in 5 years?
Based on our forecasts, a long-term increase is expected, the "SENS" stock price prognosis for 2027-06-18 is 1.029 USD. With a 5-year investment, the revenue is expected to be around +4.9%. Your current $100 investment may be up to $104.9 in 2027. Get It Now!
Is SENS a good long term investment?
Valuation metrics show that Senseonics Holdings, Inc. may be overvalued. Its Value Score of F indicates it would be a bad pick for value investors. The financial health and growth prospects of SENS, demonstrate its potential to underperform the market.
Is SENS a buy now?
Senseonics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
What is the price target for SENS?
Stock Price Target SENSHigh$6.00Median$2.50Low$0.80Average$3.10Current Price$1.18
Will Sens get FDA approval?
At long last, following a year of Covid delays, Sensonics (SENS) received the FDA's nod of approval for its long-lasting continuous glucose monitoring system (CGM).
What is the future of Sens stock?
Stock Price Forecast The 3 analysts offering 12-month price forecasts for Senseonics Holdings Inc have a median target of 2.50, with a high estimate of 6.00 and a low estimate of 0.80. The median estimate represents a +113.68% increase from the last price of 1.17.
What happen to SENS?
Senseonics Holdings (SENS) Reports Q1 Loss, Tops Revenue Estimates. Senseonics (SENS) delivered earnings and revenue surprises of 0% and 16.15%, respectively, for the quarter ended March 2022.
Is SENS a meme stock?
Both Clover Health Investments (CLOV 2.44%) and Senseonics Holdings (SENS 2.87%) have emerged as meme stocks over the last few months.
Why did Senseonics drop?
Shares of Senseonics Holdings (SENS 2.23%) were sinking 14.3% as of 3:12 p.m. EDT on Thursday. The big drop came after the medical technology company announced the pricing of a public offering of its stock.
Is SESN a good buy?
Sesen Bio Inc (NASDAQ:SESN) The 2 analysts offering 12-month price forecasts for Sesen Bio Inc have a median target of 1.78, with a high estimate of 3.00 and a low estimate of 0.56. The median estimate represents a +196.96% increase from the last price of 0.60.
How many shares does Senseonics have?
Share StatisticsAvg Vol (3 month) 34.56MShares Outstanding 5463.26MImplied Shares Outstanding 6N/AFloat 8407.5M% Held by Insiders 18.56%7 more rows
What is the price target for NIO?
Stock Price TargetsHigh$552.16Median$210.08Low$153.62Average$249.10Current Price$18.85
Should I buy or sell Senseonics stock right now?
2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Senseonics in the last year. There are currently 2 buy r...
What is Senseonics' stock price forecast for 2022?
2 Wall Street analysts have issued 12-month price objectives for Senseonics' stock. Their forecasts range from $4.00 to $6.00. On average, they pre...
How has Senseonics' stock performed in 2022?
Senseonics' stock was trading at $2.88 at the start of the year. Since then, SENS shares have decreased by 63.5% and is now trading at $1.05. View...
How were Senseonics' earnings last quarter?
Senseonics Holdings, Inc. (NYSEAMERICAN:SENS) announced its quarterly earnings data on Tuesday, May, 10th. The company reported ($0.03) earnings pe...
What guidance has Senseonics issued on next quarter's earnings?
Senseonics issued an update on its FY 2022 earnings guidance on Tuesday, June, 7th. The company provided earnings per share (EPS) guidance of for t...
Who are Senseonics' key executives?
Senseonics' management team includes the following people: Dr. Timothy T. Goodnow , Pres, CEO & Director (Age 60, Pay $1.07M) Dr. Mukul Jain ,...
Who are some of Senseonics' key competitors?
Some companies that are related to Senseonics include Mesa Laboratories (MLAB) , Hurco Companies (HURC) , Crawford United (CRAWA) , Sypris Solu...
What other stocks do shareholders of Senseonics own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Senseonics investors own include VirnetX (VHC) , Advanced...
What is Senseonics' stock symbol?
Senseonics trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "SENS."
Why SENS stock is rising
SENS stock surged sharply last week after it announced encouraging clinical trial results for its implantable CGM (continuous glucose monitoring) system. The company is working on an implantable CGM system called Eversense. The stock also became a hot discussion topic on Reddit groups, which added fuel to its rally.
SENS stock forecast on Reddit
Reddit traders have been largely positive about the forecast for SENS stock. A post on WallStreetBets, which was upvoted over 350 times, called SENS stock a "10x idea." The post talked about the market for diabetic care and also touted the company’s strategic partnership with Ascensia Diabetes Care.
Is SENS a good stock to buy?
While short squeezes can provide a short-term bump to asset prices, we also need to look at the company’s fundamentals. A lot of Reddit names have crashed, so it's important to look at the margin of safety even though it might be an oxymoron in these markets.
How high can SENS stock go?
Previously, I noted that while speculative, SENS looks like a good stock to buy. While the stock has risen sharply since mid-April, it's worthwhile to look at the stock’s risk-reward scenario now.
Where Things Stand with SENS Stock
Senseonics makes long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes. Apart from its technology, though, one reason SENS stock has risen is that the company recently reported that it raised $50 million gross from an at-the-market (ATM) equity offering program.
Where This Leaves Senseonics
This represents a fairly high multiple for the stock. For example, Yahoo! Finance recently indicated a market capitalization of $1.39 billion for SENS stock. If its 2022 sales forecast of $33 million comes through, then SENS stock trades for 42 times forward sales (i.e., $1.39 billion /$33 million).
What to Do with SENS Stock
The point here is that there’s still plenty of room for the stock to move significantly higher. Here’s an example. If we divide the $26 million in present value FCF estimate by 1.0%, the market value should be $2.6 billion. That is 87% higher than the Aug. 9 price, or $6.08 per share.
Fullgent Genetics (FLGT) Q4 Earnings and Revenues Surpass Estimates
Fullgent Genetics (FLGT) delivered earnings and revenue surprises of 25.56% and 31.01%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Senseonics Holdings, Inc. Schedules Fourth Quarter and Full Year 2021 Earnings Release and Conference Call for March 1, 2022, at 4:30 p.m. Eastern Time
GERMANTOWN, Md., February 15, 2022--Senseonics Holdings, Inc.
Sensonics: Despite FDA Approval, Expectations Are Too High, Says Raymond James
At long last, following a year of Covid delays, Sensonics (SENS) received the FDA’s nod of approval for its long-lasting continuous glucose monitoring system (CGM). The Diabetes device maker’s Eversense E3 (180-Day sensor) has now been given the go ahead and should be available to patients in the U.S.
Historical and forecast chart of Senseonics Holdings stock
The chart below shows the historical price of Senseonics Holdings stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast.
Senseonics Holdings Daily Price Targets
Forecast target price for 02-27-2022: $ 1.88. Positive dynamics for Senseonics Holdings shares will prevail with possible volatility of 3.952%.
Senseonics Holdings forecast for this year
An downtrend is forecast for this month with an optimal target price of $ 1.76529. Pessimistic: $1.58. Optimistic: $1.90
Senseonics Holdings information and performance
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
How many times will Sens stock move up?
As a result SENS stock is likely to move up 5 to 10 times in the next five years, assuming it receives Food and Drug Administration (FDA) approval for its CGM devices.
How much cash does Senseonics have?
Recently Senseonics released its earnings on Mar. 4 where it said that the company now has $187.3 million in cash on its balance sheet as of Jan. 31. This is up from $18.2 million at the end of 2020. Cash went up as a result of equity financings completed during the first quarter of 2021.
How often is Eversense XL calibrated?
This relates to its 365 days sensor designed to be calibrated only once per week, called the Eversense XL. The company is already “collaborating” with a Swiss company, Ascensia, in marketing its 90 days and 180 days sensor throughout Europe.
Why is Senseonics stock rising?
The stock is rising after the data release because investors are bullish on the results.
Who makes Eversense CGM?
Senseonics produces the Eversense CGM (continuous glucose monitoring). The market for diabetic care is expected to rise sharply given the growing number of cases. If SENS can successfully commercialize Eversense, it will be a gamechanger for the company whose current market capitalization is only around $1.6 billion.
Is Sens added to Russel 3,000?
Also, SENS is getting added to the Russel 3,000 index. The index is adding several other stocks including Fisker and Paysafe. There has been a broad-based buying in all of the stocks. Stocks tend to rise when they get added to any index. The passive funds that track the index have to buy the stocks in the proportion of their weightage, ...
Is Jim Cramer optimistic about Senseonics?
CNBC Mad Money host Jim Cramer isn't too optimistic on Senseonics stock. He sees the stock as speculative and said that the company competes with the likes of Abbott and Dexcom. Both of these companies are much larger rivals with deep pockets.
SENS : Senseonics Holdings stock forecast by Wall Street Analysts
Also, this average forecast of $6.0 represents a 100.0% increase from the past average forecast of $3.0, 6 months ago from 2 wall street analysts.
Frequently Asked Questions about Senseonics Holdings stock forecast
From Senseonics Holdings stock forecast , Senseonics Holdings (SENS) stock can be a good investment choice. According to AI Pickup, the Senseonics Holdings stock price forecast for 2022 Mar. is $3.67041233475881
